In this study, we first examined STEP61 in cases of AD and mild cognitive impairment (MCI), to determine how STEP61 expression and activity are altered over the progression of AD (Additional file 1: Materials and Methods; Table S1). Here, PTPN5 is linked to Alzheimer disease.